Hospital
Prisma Health-Midlands
Prisma Health-Midlands was paid $4.26M by Medicaid between Jan 2018 and Dec 2024, across 119 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 15% of everything it billed.
33Billing provider infoPRISMA HEALTH-MIDLANDS
COLUMBIA, SC 29212
COLUMBIA, SC 29212
33aNPI1811237985assigned 02/26/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.26M
24GClaims137,366
24DCodes billed119
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#54 of 115
Median peer was paid$2.47M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MILLER, POLLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,543 | $389K | |
| 2019 | 16,708 | $535K | |
| 2020 | 15,646 | $602K | |
| 2021 | 23,580 | $619K | |
| 2022 | 23,966 | $728K | |
| 2023 | 24,254 | $815K | |
| 2024incomplete | 21,669 | $573K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 15% | 5,607 | 5,142 | $654K |
| 80048 | Basic metabolic panel (calcium, ionized) | 12% | 4,239 | 3,900 | $509K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 11,157 | 10,706 | $488K |
| 81025 | 11% | 5,683 | 5,434 | $452K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.5% | 3,557 | 3,120 | $236K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.2% | 2,301 | 2,257 | $223K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.1% | 2,308 | 2,266 | $217K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.6% | 2,421 | 1,985 | $155K |
| 81001 | 3.3% | 7,802 | 7,312 | $143K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.2% | 4,096 | 3,767 | $136K |
| 36415 | Collection of venous blood by venipuncture | 2.6% | 1,014 | 864 | $111K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.5% | 7,427 | 6,963 | $106K |
107 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 517 | $64K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 2,139 | $56K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 754 | $49K |
| 99285 | Emergency room visit (most serious) | 1.0% | 3,911 | $44K |
| 87210 | <1% | 776 | $41K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,534 | $39K |
| 85027 | <1% | 1,265 | $36K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 318 | $33K |
| 84702 | <1% | 1,513 | $32K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 604 | $32K |
| 87081 | <1% | 234 | $30K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 596 | $26K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,133 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,704 | $25K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,722 | $25K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 901 | $21K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,759 | $20K |
| 86900 | <1% | 260 | $20K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 474 | $18K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 166 | $18K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 230 | $16K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 81 | $14K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,455 | $14K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 165 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 73 | $12K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 183 | $11K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,003 | $9K |
| 76642 | <1% | 305 | $9K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 493 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,767 | $7K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 238 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 303 | $5K |
| 77066 | Tomosynthesis, mammo | <1% | 43 | $4K |
| J3490 | Unclassified drugs | <1% | 1,233 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15 | $4K |
| 87077 | <1% | 158 | $3K | |
| 87428 | <1% | 43 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,245 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 428 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 89 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 41 | $2K |
| 84484 | <1% | 1,872 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,502 | $2K |
| 81003 | <1% | 704 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 44 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,125 | $1K |
| 72100 | <1% | 25 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 72 | $1K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 30 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 418 | $1K |
| 83690 | <1% | 2,730 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 287 | $989.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,913 | $970.23 |
| 85018 | <1% | 192 | $897.07 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 111 | $891.90 |
| 80061 | Lipid panel | <1% | 187 | $890.58 |
| 96376 | <1% | 132 | $864.37 | |
| 73630 | <1% | 13 | $861.14 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 248 | $853.93 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 428 | $853.75 |
| 73130 | <1% | 13 | $802.03 | |
| 73560 | <1% | 27 | $744.39 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 32 | $715.39 |
| 86850 | <1% | 12 | $694.85 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,938 | $474.17 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 107 | $459.83 |
| 76801 | <1% | 43 | $392.40 | |
| 73610 | <1% | 12 | $261.46 | |
| 83735 | <1% | 2,414 | $216.67 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 270 | $202.37 |
| 85379 | <1% | 198 | $174.58 | |
| 93976 | <1% | 492 | $115.30 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 871 | $112.44 |
| 86803 | <1% | 108 | $105.78 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 26 | $77.58 |
| 83880 | <1% | 16 | $65.28 | |
| 82570 | <1% | 64 | $46.77 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 196 | $42.53 |
| 83605 | <1% | 55 | $27.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,997 | $26.28 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,246 | $21.85 |
| 82947 | <1% | 17 | $20.96 | |
| 86901 | <1% | 260 | $16.05 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,444 | $14.58 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 86 | $12.91 |
| 86140 | <1% | 24 | $11.17 | |
| 85610 | <1% | 17 | $2.57 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 1,083 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 1,752 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 281 | $0.00 |
| 84703 | 0% | 24 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 71 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 13 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 78 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 59 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 24 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 12 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 118 | $0.00 |
| 80076 | 0% | 42 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 84 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 67 | $0.00 |
| 94664 | 0% | 51 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 25 | $0.00 |
| 87186 | 0% | 42 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 14 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 12 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMILLER, POLLY (SVP FINANCE, ENTERPRISE CONTRACTING)
| Provider | Location | Paid |
|---|---|---|
| Prisma Health-Midlands | Columbia, SC | $74.58M |
| Prisma Health-Midlands | Columbia, SC | $68.26M |
| Prisma Health-Upstate | Greenville, SC | $25.04M |
| Prisma Health-Upstate | Greenville, SC | $21.98M |
| Prisma Health-Upstate | Greenville, SC | $19.69M |
| Prisma Health-Upstate | Seneca, SC | $15.64M |
| Prisma Health-Midlands | Columbia, SC | $11.77M |
| Prisma Health-Upstate | Greenville, SC | $10.74M |
| Greenville Health Corporation | Greenville, SC | $8.90M |
| Prisma Health-Upstate | Greenville, SC | $8.32M |
| Prisma Health-Upstate | Greenville, SC | $7.45M |
| Prisma Health University Medical Group | Greenville, SC | $7.44M |
| Prisma Health-Midlands | Coulmbia, SC | $7.43M |
| Prisma Health-Midlands | Columbia, SC | $6.88M |
| Prisma Health Tuomey | Sumter, SC | $6.84M |
| Prisma Health-Midlands | Columbia, SC | $6.77M |
| Prisma Health-Upstate | Greenville, SC | $6.37M |
| Prisma Health-Upstate | Greenville, SC | $5.00M |
| Prisma Health-Upstate | Greenville, SC | $4.65M |
| Prisma Health-Midlands | Columbia, SC | $4.63M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.